Stock Split History
ETFs Holding TARA »    TARA Historical Stock Prices »



Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Protara Therapeutics is a clinical-stage biopharmaceutical company focused on identifying and developing transformative therapies for the treatment of cancer and rare diseases. Co.'s primary oncology program is TARA-002 in non-muscle invasive bladder cancer. Co. is also pursuing TARA-002 in lymphatic malformations, which are rare, non-malignant cysts of the lymphatic vascular system. The third development program in Co.'s portfolio is intravenous Choline Chloride, an investigational phospholipid substrate replacement therapy initially in development for patients receiving parenteral nutrition, who have intestinal failure associated liver disease. According to our Protara Therapeutics stock split history records, Protara Therapeutics has had 1 split.
Protara Therapeutics stock split history picture
Protara Therapeutics (TARA) has 1 split in our Protara Therapeutics stock split history database. The split for TARA took place on January 10, 2020. This was a 1 for 40 reverse split, meaning for each 40 shares of TARA owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 25 share position following the split.

When a company such as Protara Therapeutics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the Protara Therapeutics stock split history from start to finish, an original position size of 1000 shares would have turned into 25 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Protara Therapeutics shares, starting with a $10,000 purchase of TARA, presented on a split-history-adjusted basis factoring in the complete Protara Therapeutics stock split history. Protara Therapeutics split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 10/23/2014
End date: 03/28/2024
Start price/share: $400.00
End price/share: $4.01
Dividends collected/share: $0.00
Total return: -99.00%
Average Annual Total Return: -38.60%
Starting investment: $10,000.00
Ending investment: $100.29
Years: 9.44
Date Ratio
01/10/20201 for 40
NRx Pharmaceuticals, Inc. (NRXP)
Tritium DCFC Limited (DCFC)
Pluri Inc. (PLUR)
Rent the Runway, Inc. (RENT)
Castor Maritime Inc. (CTRM)
ETAO International Co., Ltd. (ETAO)
Aterian, Inc. (ATER)
Chipotle Mexican Grill, Inc. (CMG)
Moleculin Biotech, Inc. (MBRX)
Longeveron Inc. (LGVN)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding Protara Therapeutics
Protara Therapeutics Insider Buying

Protara Therapeutics Stock Split History | www.StockSplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.StockSplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.